Also, unlike CF patients, non-CF controls did not have a pronounced IL-2 production upon stimulation with MABSC, indicating that IL-2 may be an intrinsic player of the specific anti-MABSC or anti-NTM response. The gene discussed is IL2; the disease is cystic fibrosis.